| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/06/2008 | US20080057136 An ionogenic surfactant, a metal chelating complex with an affinity for protons, solvent and carrier; preferably cetylpyridinium chloride, EDTA-zinc complex, and isopropanol; fungicides for oral, topical or intravenous administration; dandruff, acne, dermatitis |
| 03/06/2008 | US20080057133 Preparation of Aqueous Clear Solution Dosage Forms with Bile Acids |
| 03/06/2008 | US20080057131 Glycolic acid-lactic acid copolymer matrix incorporated with a peptide drug and a corticosteroid; sustained release for two weeks; improved bioavailability |
| 03/06/2008 | US20080057115 2-propyloctanoic acid for treating neurodegenerative diseses contained in a capsule, internally taken safely without feeling acidness, pain, burning sensation in the oral cavity, dissoved quickly in stomach without delay; shell comprises gelatin, sacchride as base and glycerine as plasticizer, a fat |
| 03/06/2008 | US20080057110 Compositions for alcoholic beverages and methods of producing thereof |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057108 Functional food and method for preparation thereof |
| 03/06/2008 | US20080057087 Coating polymer solution onto inert substrate by knife or roller application or spraying and drying, using partially hydrolyzed polyvinyl alcohol, soluble in water; then coating second composition based on polyvinylpyrrolidone, soluble in water, for second layer; quick dissolving; drug delivery |
| 03/06/2008 | US20080057083 Protecting an animal against a pathogen by administering protective agent which is able to stimulate the animal's immune system to produce a response which is protective against the pathogen, and an immunostimulant comprising a polycationic carbohydrate or derivative thereof; non-parenteral immunization |
| 03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 03/06/2008 | US20080057048 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders |
| 03/06/2008 | US20080057030 comprising administering an effective amount of Interferon-gamma (IFN-gamma) and corticosteroids; treatment of respiratory system disorders |
| 03/06/2008 | US20080057026 Amphiphilic Star-Like Or Scorpion-Like Macromolecules, Various Compositions And Uses Threof |
| 03/06/2008 | US20080057014 Personal care composition comprising hydrophobic gel |
| 03/06/2008 | US20080057003 Powder inhaler formulations |
| 03/06/2008 | US20080056996 Photodynamic therapy for the treatment of hair loss |
| 03/06/2008 | DE10136781B4 Flache orale Darreichungsformen mit wirkstoffhaltigen Partikeln Flat oral dosage forms with drug-containing particles |
| 03/06/2008 | CA2662197A1 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 03/06/2008 | CA2662178A1 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 03/06/2008 | CA2662164A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | CA2662062A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
| 03/06/2008 | CA2661995A1 Antigenic protein conjugates and process for preparing same |
| 03/06/2008 | CA2661912A1 Drug electrotransport with hydration measurement of hydratable reservoir |
| 03/06/2008 | CA2661764A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 03/06/2008 | CA2661754A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 03/06/2008 | CA2661521A1 Pharmaceutical compositions comprising hgh for oral delivery |
| 03/06/2008 | CA2661078A1 Lyophilized preparation |
| 03/06/2008 | CA2658736A1 Method for the production of insulin-like growth factor-i |
| 03/06/2008 | CA2645037A1 Pharmaceuticals containing fluoroquinolones |
| 03/05/2008 | EP1894582A1 Method for control of drug elution rate and composition for coating of drug-eluting stent |
| 03/05/2008 | EP1894573A2 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 03/05/2008 | EP1894563A1 Plaster containing fentanylum |
| 03/05/2008 | EP1894559A1 Means to solubilise steroids for inhalation |
| 03/05/2008 | EP1894557A1 Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore |
| 03/05/2008 | EP1893661A2 Strategies for delivery of active agents using micelles and particles |
| 03/05/2008 | EP1893396A2 Foamable vehicle and pharmaceutical compositions thereof |
| 03/05/2008 | EP1893241A2 Fluorescent nanoparticles conjugated to antibodies via a peg linker |
| 03/05/2008 | EP1893240A2 Transmucosal delivery of peptide derivatives |
| 03/05/2008 | EP1893239A2 Transglutaminase mediated conjugation of growth hormone |
| 03/05/2008 | EP1893238A1 Macromolecular conjugates of bone morphogenetic protein-7 |
| 03/05/2008 | EP1893237A1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle |
| 03/05/2008 | EP1893231A2 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 03/05/2008 | EP1893230A2 Use of modified factor vii for treating bleeding |
| 03/05/2008 | EP1893204A2 Formulations comprising fluphenazine or derivatives thereof |
| 03/05/2008 | EP1893178A1 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS |
| 03/05/2008 | EP1893175A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 03/05/2008 | EP1893159A1 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 03/05/2008 | EP1613343A4 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 03/05/2008 | EP1611173B1 Polymeric modifiers and pharmaceutical compositions |
| 03/05/2008 | EP1564236B1 Polyalkylen glycol derivative |
| 03/05/2008 | EP1558290A4 Heat pasteurized liquids containing glucosamine |
| 03/05/2008 | EP1368253B1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 03/05/2008 | EP1233969B1 Mono- and disaccharide derivatives |
| 03/05/2008 | EP1144609B1 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/05/2008 | EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics |
| 03/05/2008 | EP1059942B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 03/05/2008 | CN101137756A Method for the production of hyperbranched polysaccharide fractions |
| 03/05/2008 | CN101137755A Method for gene delivery to neuronal cells |
| 03/05/2008 | CN101137700A Microparticle and pharmaceutical composition |
| 03/05/2008 | CN101137673A Cripto结合分子 Cripto binding molecules |
| 03/05/2008 | CN101137396A Production of bioactive glycoproteins from inactive starting material |
| 03/05/2008 | CN101137395A Pharmaceutical composition containing hardly water soluble medicament |
| 03/05/2008 | CN101137383A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution |
| 03/05/2008 | CN101137364A Compositions comprising an epothilone and production methods |
| 03/05/2008 | CN101137356A Adhesive and plaster |
| 03/05/2008 | CN101137355A Non-fibrous transdermal therapeutic system and method for its production |
| 03/05/2008 | CN101137349A Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 03/05/2008 | CN101137348A Microemulsions of cannabinoid receptor binding compounds |
| 03/05/2008 | CN101134785A Colonic microflora degradation material and preparation method and uses thereof |
| 03/05/2008 | CN101134784A Agarose and hyaluronic acid grafts and preparation method and uses thereof |
| 03/05/2008 | CN101134110A Q type non-viral vector and pharmaceutical composition containing the same |
| 03/05/2008 | CN101134109A Anticancer prior-medicine and method for preparing the same and use thereof |
| 03/05/2008 | CN101134108A Desonide cyclodextrin clathrate compound and method for preparing the same |
| 03/05/2008 | CN101134050A Pharmaceutical composition for reinforcing organism immunity and technique of preparing the same |
| 03/05/2008 | CN101134038A 缓释的口服给药组合物 The sustained-release composition for oral administration |
| 03/05/2008 | CN101134037A Rimonabant or the enteric-coated preparations of the rimonabant medical salts and method for preparing the same |
| 03/05/2008 | CN101134034A Immunological enhancement medicine and method for preparing the same |
| 03/05/2008 | CN101134033A Famotidine oral cavity disintegrating lyophilized tablets and method for preparing the same |
| 03/05/2008 | CN101134028A Artinoid ethyltester capsule |
| 03/05/2008 | CN101134026A Vinorelbine soft capsule and method for preparation and application thereof |
| 03/05/2008 | CN101134022A Lyophilized orally disintegrating tablets with better mechanical property and method for preparing the same |
| 03/05/2008 | CN101134018A Fenofibrate pellet and method for preparing the same |
| 03/05/2008 | CN101134017A Liposome composition for carrying agentia for treating eyes |
| 03/05/2008 | CN101134014A Calcium sulphate bead string implantation type medicine partial releasing system with top coat and method of producing the same |
| 03/05/2008 | CN101134013A Preparations for oral administration |
| 03/05/2008 | CN101134012A Method for producing injectable drug administration preparations using mixed polyacid anhydride as the carrier for middle-size or small molecule medicament and application thereof |
| 03/05/2008 | CN100373375C System and method for controlling user interface attribute by data |
| 03/05/2008 | CN100372599C Preparation method of nucleous-shell type nanometer composite particle of magnetic micro particle and quantum point |
| 03/05/2008 | CN100372571C Chitosan-immune RNA composite formulation and preparation method thereof |
| 03/05/2008 | CN100372570C Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastsis or preventing the recurrence of maligant tumor |
| 03/05/2008 | CN100372569C Dendrimer-photosensitizer complexes for medical applications |
| 03/05/2008 | CN100372567C Thrombin derived peptides for promoting cardiac tissue repair |
| 03/05/2008 | CN100372566C Targeted delivery of drugs for treatment of viral infections |
| 03/05/2008 | CN100372536C Tablets quickly disintegrated in oral cavity |
| 03/05/2008 | CN100372531C Percutaneous absorption preparations containing 3-methyl-phenyl-2-pyrazolin-5-one |
| 03/05/2008 | CN100372529C Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 03/05/2008 | CN100372526C Warm poultice |
| 03/05/2008 | CN100372524C Amphotericin B nano preparation |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339013 Thermosensitive polymers and thermoreversible gels obtained from these polymers |